HSP90B1 and Fulminant hepatitis: Given that the symptoms fulminant hepatitis or acute of chronic liver failure in CHB may last for weeks to months, and gp96-induced protection appears as early as 10 d after gp96 administration, we believe that induction of Tregs by gp96 administration may probably provide an effective strategy for treatment of immune-induced liver injury in fulminant hepatitis.